Out with the old, in with the new… CEOs. Pharma's top-level rejigs

Image: iStock/CreativaImages

Valeant, Rentschler, Celgene, MannKind, and Syngene are among those welcoming new leaders for 2016. Oh, and Turing waves goodbye to Martin Shkreli… welcome to a New Year’s CEO special.

Related News

Image: iStock/Suradin Suradingura

MannKind withdraws job offer a week after Insulet's ex-CEO was set to start

The largest risks to biopharma companies is capital stability and clinical results. (Image: iStock)

Biopharma CEO confidence levels wavering

Image: iStock/SixtyOneProductionsLtd

Valeant gives six months timeline for FL plant reinspection after eye drug CRL

Rentschler doubles capacity with new manufacturing plant

Rentschler doubles capacity with new manufacturing plant

Isys CEO resigns; job news at Merck and BI

Isys CEO resigns; job news at Merck and BI

Actelion's Jean-Paul Clozel was picked as a top European pharma CEO

European pharma: CEO talent is the new measure of company calibre

People on the move: Aegerion CEO resigns

People on the move: Aegerion CEO resigns

Christopher O'Connell is the new CEO of Waters.

People on the Move: CEO switch for Waters